Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Curtis Cooper
University of Ottawa
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
57
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Covid-19 Vaccine Immunogenicity and Safety Surrounding Fourth and Subsequent Vaccine Doses in Patients with Hematologic Malignancies
Number of pages: 25
Posted: 12 Mar 2024
Sita Bhella
,
Allison M. Wilkin
,
Katrina Hueniken
,
Abi Vijenthira
,
Michael Sebag
,
Peng Wang
,
Lisa K. Hicks
,
Annette E. Hay
,
Sarit Assouline
,
Graeme Fraser
,
Joy Mangel
,
Carolyn Owen
,
Anthony Reiman
,
Laurie H. Sehn
,
Heather Sutherland
,
Tinghua Zhang
,
Corey Arnold
,
Tamara Leite
,
Erinn McCarthy
, Curtis Cooper,
Marc-Andre Langlois
and
C. Arianne Buchan
University of Toronto, University of Ottawa, University of Toronto, University of Toronto, McGill University, University of Alberta, University of Toronto, Queen's University, Jewish General Hospital, Montreal, McMaster University, Western University, University of Calgary, Saint John of God Hospital, University of British Columbia (UBC), University of British Columbia (UBC), University of Ottawa - Ottawa Hospital Research Institute, University of Ottawa, University of Ottawa - Ottawa Hospital Research Institute, University of Toronto, University of Ottawa, University of Ottawa and University of Ottawa
Downloads
57
(989,921)
View PDF
Download
Abstract:
hematologic malignancies, COVID-19 vaccination, fourth and subsequent COVID-19 vaccines
Feedback